Skip to content
Delayed ~15 min

GEHC GE HealthCare

Health Care · S&P 500 · Nasdaq 100

Next earnings: not announced yet

What 27 analyst firms say about GE HealthCare: their latest ratings, price targets and how far the stock is from them. How it works

82.38 USD−1.37 (−1.64%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

−1.0%to the avg target 81.58 USD−0.80 USD
Buy 15 · Hold 10 · Sell 0

25 rated views · 28 analyst/firm records · 27 firms

Latest report29 Oct 2026avg report date 23 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MNot scored · Average target is not above the current price
  • S&P 500 · Safest consensus · 6MNot scored · Average target is not above the current price
Other indices (1)
  • Nasdaq 100 · Top Picks · 6MNot scored · Average target is not above the current price
  • Nasdaq 100 · Safest consensus · 6MNot scored · Average target is not above the current price

Recent analyst activity · last 90 days

Our tracked history has 22 reports on GEHC from 15 analyst firms in the last 90 days (27 firms in the past year).

Comparing each firm's latest target with its previous one: 7 raised their price target, 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: UBS raised its target from $73.00 (set 31 Jul 2026) to $80.00 on 3 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid A ToungBuy4 Mar 202685.00 USD
Bank of America SecuritiesCraig BijouHold5 Jan 202692.00 USD
BarclaysChristopher PasqualeBuy29 Oct 202695.00 USD
BMO Capital MarketsVikramjeet S ChopraHold8 Jul 2026Conflicting reports · excluded
BNP Paribas ExaneNavann TyBuy31 Jul 2026Conflicting reports · excluded
BTIGRyan ZimmermanBuy28 Oct 202683.00 USD
CitigroupJoanne WuenschHold29 Oct 2026Conflicting reports · excluded
DBSNico ChenBuy1 Jul 2026100.00 USD
Evercore ISIVijay KumarBuy28 Oct 202684.00 USD
Goldman SachsDavid RomanHold8 Jun 202665.00 USD · 30 Apr 2026
Hovde GroupUnnamed analystHold17 Jul 202614.00 USD
HSBCUnnamed analyst—30 Apr 202690.00 USD
JefferiesMatthew C TaylorBuy29 Oct 202695.00 USD
JPMorganRobbie MarcusHold29 Oct 202680.00 USD
MizuhoAnthony PetroneBuy29 Oct 202690.00 USD
Morgan StanleyPatrick WoodHold4 Feb 202685.00 USD
NeedhamDavid SaxonBuy5 Oct 202693.00 USD
OppenheimerSuraj KaliaBuy30 Jul 2026—
Piper SandlerJason BednarBuy28 Oct 2026—
RBC Capital MarketsKendall AuBuy29 Oct 202690.00 USD
RBC Capital MarketsShagun SinghBuy5 Oct 2026—
RedburnEd Ridley-DayBuy31 Jul 2026Conflicting reports · excluded
StifelUnnamed analyst—29 Apr 202680.00 USD
UBSGraham DoyleHold31 Jul 202673.00 USD
Weiss RatingsUnnamed analyst—6 Oct 2026—
Wells FargoLarry BiegelsenBuy30 Jul 202685.00 USD
Wolfe ResearchMike PolarkHold20 Oct 2026—
Data feed RESEARCHResearch TeamHold11 Aug 202671.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 03:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.